logo
#

Latest news with #Phipps

William Blair Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX)
William Blair Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX)

Business Insider

time3 days ago

  • Business
  • Business Insider

William Blair Sticks to Its Buy Rating for Vertex Pharmaceuticals (VRTX)

William Blair analyst Matt Phipps reiterated a Buy rating on Vertex Pharmaceuticals (VRTX – Research Report) yesterday. The company's shares closed last Friday at $441.30. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Phipps covers the Healthcare sector, focusing on stocks such as Cullinan Management, Genmab, and Bristol-Myers Squibb. According to TipRanks, Phipps has an average return of -9.1% and a 36.43% success rate on recommended stocks. In addition to William Blair, Vertex Pharmaceuticals also received a Buy from H.C. Wainwright's Andrew Fein in a report issued on June 23. However, on June 27, RBC Capital maintained a Hold rating on Vertex Pharmaceuticals (NASDAQ: VRTX).

New Orleans Financial Collab Gets $1M Grant To Invest In Local Start-Ups
New Orleans Financial Collab Gets $1M Grant To Invest In Local Start-Ups

Yahoo

time25-06-2025

  • Business
  • Yahoo

New Orleans Financial Collab Gets $1M Grant To Invest In Local Start-Ups

JPMorgan Chase has committed $1 million to help three New Orleans non-profit organizations. The Financial Wellness Collaborative received funds to help bolster its overall mission of providing small businesses with hands-on tools to manage their financial health. Financial Wellness Collaborative consists of nonprofit Propeller, Thrive New Orleans, and Fund 17, NOLA reported. Launching in 2022, JPMorgan Chase has given the collaborative its most significant investment to date. Victoria Adams Phipps, Vice President of Global Philanthropy at JPMorgan Chase, spoke at the June 24 ceremony. Phipps praised the work that the Financial Wellness Collaborative has already accomplished. She noted that the Propeller team was proactive in its pursuit of JPMorgan Chase's investment, and it has paid off. 'We supported that initial pilot of the work back in 2022, and we were thrilled to see that the model worked,' she said. Phipps also noted that the ability to obtain capital for scaling up has been a consistent issue in the community. She is confident in the tools offered by the Financial Wellness Collaborative, and 'building relationships over time' was the missing key for many of New Orleans' small businesses. With the support of Propeller, Thrive New Orleans, Fund 17, and JPMorgan Chase, over 400 businesses have taken the next step in their growth. 'Many of the companies they were in conversation with were lacking critical inputs that were necessary to facilitate growth,' she said. 'That might have been access to networks, expertise or customers. But for many of them, it was access to capital that was hindering their progress.' The grant enables the Financial Wellness Collaborative to continue offering services to entrepreneurs, including financial coaching, credit counseling, loan package preparation, accounting assistance, and support for obtaining credentials. Former recipient of the program, Travis Williams of Nola Steele, spoke highly of the services provided. According to Steele, he was able to organize his operations and secure funding after gaining assistance. 'We have great credit scores, and we have great relationships with other banks, yet we weren't able to get the financial backing that we needed until we brought it up with Propeller and Thrive,' he said. RELATED CONTENT: More Americans Need 6 Figures To Feel Financially Secure Sign in to access your portfolio

Couple bought an abandoned house in Vancouver for a $1.5 million, has spent over $250,000 renovating so far—take a look inside
Couple bought an abandoned house in Vancouver for a $1.5 million, has spent over $250,000 renovating so far—take a look inside

CNBC

time16-06-2025

  • Business
  • CNBC

Couple bought an abandoned house in Vancouver for a $1.5 million, has spent over $250,000 renovating so far—take a look inside

In 2023, Nick Volkov came across a listing for a property in Vancouver, British Columbia, and knew immediately that he had to show his girlfriend, Jenna. Though the listing shared photos of just the exterior and described the house as a "tear-down," the 28-year-old program manager tells CNBC Make It that what stood out the most was that the property was priced much lower than those in the surrounding area. Plus, it had a view of the water, and wasn't your standard modern home. Jenna Phipps, a 29-year-old content creator, says she fell in love, but wanted to get out to see the house in person as soon as possible. "There was a reason they didn't show photos of the inside," she says. The Vancouver property is a 2,757-square-foot single-family home, built in 1961. It had three bedrooms, 2.5 bathrooms, a pool, and sits on 0.30 acres. The house was so dilapidated that the realtor asked the couple to sign a waiver before going inside. "You can really see this property had not been cared for at all," Volkov says. "There was a really musty smell with the old furniture and old things in there." Still, the couple were able to find some beauty in the space. "The architecture showed through all of that. You could see what it was in its former days," Volkov says. "Even with it falling apart, it was still really pretty." The couple made an offer of $2.1 million CAD — $1,525,923 USD at the time — and it was accepted. They closed on the property in January 2024. "People were very shocked at how we were able to get that price, especially in that area," Phipps says. "We kind of bought the worst thing in a great neighborhood." The median list price of homes in Vancouver was $1,578,540 in March 2024, according to Houseful, a subsidiary of the Royal Bank of Canada. The property's rundown condition meant Volkov and Phipps were unable to obtain a traditional mortgage and had to apply for a private two-year loan instead. They split the 20% down payment evenly. When Phipps and Volkov took possession of the house, it had been empty for four years and was deteriorating. The seller lived several hours away and would rarely visit. "It was in a state that probably no one should have lived there," Phipps says. When the couple closed on the house in 2024, their first order of business was clearing it out. They had hopes of preserving some of the structure's original features, like the wood paneling, but ended up having to take the house down to the studs. There was extensive water damage and mold that had grown over the years that the house was abandoned. That summer, Volkov and Phipps worked to get rid of the roof, windows, ducting, and electrical. In October, the couple hired contractors to help rebuild the roof and frame of the house. "We're pretty much at the stage where it feels like a real home," she says. The couple did most of the work on their new home themselves. They would work six days at the house from 7:30 a.m. until 5:30 p.m. while documenting the journey for Phipps' YouTube channel. On Sundays, they would spend most of the day working on content creation. "We work really hard because we want to keep showing videos and showing a process to everyone," Phipps says. "Having that support from so many people cheering us on, I think that was great accountability, too." Phipps says the renovation process has been hard, but even just getting windows installed helped them picture what life will be like once they can finally move in. "For a while over the winter, it was mentally challenging and now we're finally at that exciting stage where we actually see it. I think we're finally enjoying all this hard work we put in." The couple will pay homage to the original space by having some of the wood paneling details restored. "We look at the home and we're like 'Wow, this is beautiful.' We have the exact same home but just a new form. We pretty much recreated it," Phipps says. Volkov and Phipps are planning to replicate some of the original furniture that came with the sale of the house, but that they had to get rid of. They also modified the floor plan slightly to make the house a four-bedroom, two-and-a-half-bathroom, and kept the exterior the same. The couple had an initial budget of $220,792 USD with a max limit of $294,389. They've since gone over budget and had to readjust. Phipps says they've already spent over $257,590 and is hoping to stay at or under $441,583 going forward. "We chose to go over budget because we're going the extra mile to have a better quality home," she says. "It's obviously not the greatest thing to see higher bills come in, but we're so invested in this project. It's an investment and that's how we're looking at it." The couple plans to transition to a traditional mortgage next January. "We're hoping that it will be at that livable standard so we can get it reevaluated with a traditional bank," Phipps says. "We would love to move in by the end of the year, so we're working very hard to try to still get to that goal." Phipps knew from the very beginning that once it became theirs's, she didn't want to ever sell the house. Now that they've put in a year's worth of work, she's even more adamant about that. "I don't think there would ever be a price tag out there that I would be able to sell it for or at least not anytime soon," she says. "I really want to enjoy the home." 74

Analyst Says NewAmsterdam Stock Has Over 100% Upside, Citing 90% Success Probability For Obicetrapib
Analyst Says NewAmsterdam Stock Has Over 100% Upside, Citing 90% Success Probability For Obicetrapib

Yahoo

time09-06-2025

  • Business
  • Yahoo

Analyst Says NewAmsterdam Stock Has Over 100% Upside, Citing 90% Success Probability For Obicetrapib

NewAmsterdam Pharma Company N.V. (NASDAQ:NAMS) on Monday released topline data from pre-specified Alzheimer's Disease biomarker analyses in the Phase 3 BROADWAY clinical trial. The study was primarily designed to evaluate the efficacy of obicetrapib in lowering low-density lipoprotein cholesterol (LDL-C) in adult patients with established atherosclerotic cardiovascular disease (ASCVD) and/or heterozygous familial hypercholesterolemia (HeFH), whose LDL-C is not adequately controlled despite being on maximally tolerated lipid-lowering therapy. A pre-specified sub-study was conducted to assess the effect of obicetrapib on plasma biomarkers of Alzheimer's in the full study population and patients carrying the ApoE4 company plans to present the full results from the AD sub-study analysis in a Developing Topics oral presentation at the Alzheimer's Association International Conference in Toronto at the end of July 2025. The primary endpoint was the LS mean percent change from baseline in LDL-C of obicetrapib 10 mg compared to placebo after 84 days, which showed a 33% reduction with imputation. Secondary endpoints also included percent changes from baseline of obicetrapib 10 mg compared to placebo in ApoB, Lp(a), ApoA1, HDL-C, non-HDL-C, total cholesterol, and triglycerides at day 84, and on LDL-C levels at days 180 and 365. Other exploratory outcome measures included time from randomization until the first confirmed occurrence of MACE in the obicetrapib arm compared to the placebo. The trial also evaluated the safety and tolerability profile of obicetrapib. In a note to investors, the investment firm William Blair expressed continued confidence in NewAmsterdam Pharma's drug, obicetrapib, following the release of new clinical trial data. William Blair analyst Matt Phipps said, 'We continue to believe obicetrapib will offer a differentiated product profile in the marketplace, and while we have not factored in Alzheimer's benefit to our current assumptions, this could clearly provide significant long-term continue to believe seeing LDL reductions below 55% would be a positive for NewAmsterdam, particularly utilization of the fixed-dose-combination with ezetimibe.' William Blair maintained an Outperform rating on NewAmsterdam Pharma, citing a 90% probability of success for obicetrapib. The analyst has derived a fair value for NewAmsterdam shares of $43. Phipps asserted that obicetrapib could achieve a significant and clinically meaningful reduction in cardiovascular outcomes in the ongoing Phase 3 PREVAIL trial, potentially achieving a 20% or greater relative risk reduction. Price Action: NAMS stock is trading lower by 1.04% to $19.93 at last check Monday. Read Next:Photo via Shutterstock Up Next: Transform your trading with Benzinga Edge's one-of-a-kind market trade ideas and tools. Click now to access unique insights that can set you ahead in today's competitive market. Get the latest stock analysis from Benzinga? This article Analyst Says NewAmsterdam Stock Has Over 100% Upside, Citing 90% Success Probability For Obicetrapib originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Excelsior dominate Athletic Marist despite messy start in heavy rain
Excelsior dominate Athletic Marist despite messy start in heavy rain

Otago Daily Times

time08-06-2025

  • Sport
  • Otago Daily Times

Excelsior dominate Athletic Marist despite messy start in heavy rain

Winter was in full swing in North Otago on Saturday as wet and windy conditions welcomed all six teams back after they had last weekend off. Part two of the Battle of the Carpark featured Excelsior beating Athletic Marist 27-5. The opening 20 minutes were messy from both sides as heavy rain made handling the ball tough. Once it started to clear up, Blues were able to string some phases together in Athletic's territory. Quick recycled ball allowed Tasilisili Ika to crash over in the corner. Excelsior were hot on attack a few minutes later when Josh Phipps calmly dropped back in to the pocket and slotted a drop goal to give his side a double-digit lead. They continued to dominate possession and territory but could not crack the strong Athies defence. However, Phipps was able to keep adding points off the tee as he nailed four penalty kicks at goal to give Blues a 22-0 lead with 15 minutes to play. A sliver of hope was offered to Athies when a messy exit from Blues was hacked through by Athies, who won a penalty, giving them a great attacking opportunity. They tapped it quickly and their forwards went to work. Alifereti Matirewa scored to keep their hopes alive. However, Alfie Coop did not get the chance to kick the conversion as the referee ruled he had taken a step forward, allowing Blues to rush up and knock it off the tee before he got there. It did not matter in the end as hooker Hozayah Taylor scored off the back of a driving maul to clinch the win for Excelsior. It was a gutsy effort from Blues in the wet, and they were led by Phipps and halfback Tyron Davies. The pair drove their team around the park and made good decisions all day. Fullback Liam Direen has also quietly strung together an impressive season in the back three. Valley have now won six in a row and find themselves on top of the table after beating Old Boys 22-19. It was not all smooth sailing as they trailed 19-7 at halftime. They really kicked into gear in the second 40, scoring three unanswered tries and keeping Old Boys scoreless. Maheno beat Kurow 27-17 for their first win of the year. It has been a tough season for the green machine, but they have continued to front up and finally got the rewards on Saturday.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store